NewGenIvf (NIVF) Revenue: 2021-2024
Historic Revenue for NewGenIvf (NIVF) over the last 4 years, with FY2024 value amounting to $5.4 million.
- NewGenIvf's Revenue fell 1294.15% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year change of. This contributed to the annual value of $5.4 million for FY2024, which is 578.69% up from last year.
- According to the latest figures from FY2024, NewGenIvf's Revenue is $5.4 million, which was up 578.69% from $5.1 million recorded in FY2023.
- In the past 5 years, NewGenIvf's Revenue registered a high of $5.9 million during FY2022, and its lowest value of $4.1 million during FY2021.
- Its 4-year average for Revenue is $5.2 million, with a median of $5.3 million in 2023.
- As far as peak fluctuations go, NewGenIvf's Revenue skyrocketed by 4434.23% in 2022, and later tumbled by 1359.37% in 2023.
- NewGenIvf's Revenue (Annual) stood at $4.1 million in 2021, then soared by 44.34% to $5.9 million in 2022, then decreased by 13.59% to $5.1 million in 2023, then rose by 5.79% to $5.4 million in 2024.
- Its last three reported values are $5.4 million in FY2024, $5.1 million for FY2023, and $5.9 million during FY2022.